CANNAPHARMARX, INC. Stock Issued During Period, Value, Acquisitions
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CANNAPHARMARX, INC. stock issued during period, value, acquisitions for the quarter ending 2020-06-30 was $2.48M, a 49568340.00% increase year-over-year.
- CANNAPHARMARX, INC. stock issued during period, value, acquisitions for the quarter ending 2019-12-31 was $5.46M, a 238.86% increase year-over-year.
- CANNAPHARMARX, INC. stock issued during period, value, acquisitions for the quarter ending 2019-06-30 was $5.00.
- CANNAPHARMARX, INC. stock issued during period, value, acquisitions for the quarter ending 2019-03-31 was $11.26M.
- CANNAPHARMARX, INC. stock issued during period, value, acquisitions for fiscal 2019 was $11.26M, a 598.53% increase from fiscal 2018.
- CANNAPHARMARX, INC. stock issued during period, value, acquisitions for fiscal 2018 was $1.61M.
- CANNAPHARMARX, INC. stock issued during period, value, acquisitions for fiscal 2014 was $296.00K.
| Period end | Stock Issued During Period, Value, Acquisitions 3 month | Stock Issued During Period, Value, Acquisitions 12 month |
|---|---|---|
| 2020-06-30 | $2.48M 10-Q · filed 2020-11-12 | |
| 2019-12-31 | $5.46M derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-14 | $11.26M 10-K · filed 2021-04-14 |
| 2019-06-30 | $5.00 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $11.26M 10-Q · filed 2020-11-12 | |
| 2018-12-31 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-27 | $1.61M 10-K · filed 2020-05-27 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-11 | $296.00K 10-K · filed 2018-09-11 |